Healthy Life Agritec rights issue terms due Sep 29, 2026

What the company has announced

Healthy Life Agritec has disclosed a proposed rights issue and a fresh board meeting to decide the detailed commercial terms. The company has already approved a fundraising plan of up to ₹5,000 lakh (₹50 crore) through equity shares via a rights issue. However, it has said that key items such as the issue price, record date, payment mechanism, and rights entitlement ratio are still to be determined. The company’s disclosures indicate the issuance will be through partly paid-up equity shares with a face value of ₹10 each. The final terms are also subject to receiving in-principle approval from BSE Limited.

Board meeting on September 29, 2026: decisions pending

Healthy Life Agritec will convene a Board of Directors meeting on September 29, 2026 to determine the specific terms of the proposed rights issue. The agenda includes finalising the issue price, the payment mechanism, the rights entitlement ratio, and the record date. The company has indicated these decisions will be taken after factoring in required approvals, including BSE’s in-principle clearance. Until these items are decided and disclosed, investors do not have confirmed information on the exact pricing and entitlement structure for the proposed ₹50 crore rights issue.

Earlier approval on September 23, 2026: fundraise cleared in principle

The fundraising plan was approved earlier at a board meeting held on September 23, 2026. In that meeting, the board approved raising funds through a rights issue of up to ₹50 crore, via partly paid-up equity shares. The company also stated that the detailed terms of the issue had not been finalised at that point. It added that the record date and issue price were yet to be determined and that the fundraise is subject to applicable regulatory approvals.

Rights Issue Committee formed for execution

To oversee the execution of the rights issue, the Board has constituted a Rights Issue Committee. The committee includes Divya Mojjada as Chairperson, with Mohammed Sadiq and Apra Sharma as members. The company’s disclosure also recorded procedural details of the earlier board meeting, noting it commenced at 12:00 pm and concluded at 1:45 pm. The formation of a committee signals the company’s intent to move the process forward once the final commercial terms are approved.

Separate rights issue information: record date, price, ratio

The provided information also includes a set of rights issue terms stating a record date of 26-Sep-2025/26-09-2025, an issue price of ₹10 per share, and a rights ratio of 1:1, with a subscription period from 10-09-2025 to 26-09-2025. This section further states that each share carries a face value of ₹10. These details appear as standalone rights issue terms and are not described as the same issue that the company is currently finalising through the September 2026 board process. Readers should therefore rely on the company’s latest exchange disclosures for the upcoming issue, where the record date and price are explicitly stated as pending.

AGM schedule and shareholder voting window

Healthy Life Agritec has also confirmed its seventh annual general meeting (7th AGM) for September 26, 2026 at 12:30 pm, to be held via video conference or other audio-visual means. Remote e-voting is scheduled to open on September 23, 2026 at 9:00 am and close on September 25, 2026 at 5:00 pm. The company said it dispatched its FY26 annual report to shareholders who did not have registered email addresses. It also appointed M/s. Mayuri Sinha & Co., Practicing Company Secretaries, as the scrutinizer to oversee the e-voting process.

FY26 reference point: ₹24.81 crore raised via rights issue

In its FY26 context, the company stated it raised ₹24.81 crore through a rights issue by allotting 2.48 million equity shares at ₹10 each. It said the proceeds were primarily used for working capital requirements and general corporate purposes. The company also disclosed that it increased its authorised share capital to ₹50 crore. This historical fundraising provides context for how the company has previously structured and deployed rights issue proceeds.

Key facts at a glance

Market impact: what is confirmed, and what is not

The confirmed market-relevant point is that the board has approved a rights issue fundraising plan of up to ₹50 crore, but the commercial terms are pending. Until the company discloses the issue price, record date, ratio, and payment terms, shareholders cannot quantify their entitlement or evaluate dilution and cash outflow requirements. The company has also made it clear that the process is subject to regulatory approvals, including in-principle approval from BSE. Separately, the FY26 disclosure of raising ₹24.81 crore through a ₹10 issue price and 2.48 million shares provides a reference point for the company’s past capital-raising approach, but it does not confirm the pricing for the upcoming proposal.

Why the September 29 meeting matters

The September 29, 2026 board meeting is the key trigger for final clarity on the proposed rights issue. The outcome should establish the issue price, record date, and rights ratio, which together determine who is eligible and how many shares can be applied for. It should also clarify the payment mechanism for partly paid-up equity shares, a detail that affects the timing and extent of cash payments by subscribing shareholders. The company has already put governance mechanisms in place by forming a Rights Issue Committee, which typically supports execution after terms are approved.

Conclusion

Healthy Life Agritec has approved a rights issue plan of up to ₹50 crore and is set to meet on September 29, 2026 to finalise the issue’s key terms, subject to BSE’s in-principle approval. Investors will be watching for the company’s post-meeting disclosure covering the issue price, ratio, record date, and payment structure.